SEC Filings
Government Disclosures
Contracts + Permits
Earnings + IPOs
Treasury Yields
ETF Explorer
Short Volume
Screener
Stock Research
Portfolio Lab
About
Settings
Contact
Koppel Adam | Tormere
← Back
Koppel Adam
Director
SEC EDGAR ↗
Total Purchases
$25.0M
1 transaction
Total Sales
—
0 transactions
Companies Traded
1
1 total filings
Active Since
2026-04-20
Last: 2026-04-20
Companies
KLRA
2026-04-20
Kailera Therapeutics, Inc.
↑ $25.0M (1)
Transaction History
Date
Ticker
Type
Shares
Price
Value
Owned After
2026-04-20
KLRA
Purchase
1.56M
$16.00
$25.0M
22.58M
SEC ↗